肝脏 ›› 2024, Vol. 29 ›› Issue (4): 408-413.

• 肝癌 • 上一篇    下一篇

Sulfiredoxin-1对肝癌细胞铁死亡的影响及其机制研究

许兴文, 贾瑾堂   

  1. 730070 兰州 甘肃省中心医院普外二科
  • 收稿日期:2023-05-09 出版日期:2024-04-30 发布日期:2024-08-27
  • 通讯作者: 贾瑾堂,Email:jiajintangjjt@outlook.com

The effect and mechanism of Sulfiredoxin-1 on ferroptosis in hepatocellular carcinoma cells

XU Xing-wen, JIA Jin-tang   

  1. Department II of General Surgery,Gansu Province Central Hospital,Lanzhou 730070, China
  • Received:2023-05-09 Online:2024-04-30 Published:2024-08-27
  • Contact: JIA Jin-tang, Email:jiajintangjjt@outlook.com

摘要: 目的 探讨Sulfiredoxin-1(SRXN1)对肝癌细胞铁死亡的影响及其相关机制。方法 将HepG2细胞分为以下三组:阴性对照+二甲基亚砜(NC + DMSO)组、NC + erastin(铁死亡诱导剂,10 μM)组和si-SRXN1 + erastin组。采用铁含量测定试剂盒检测各组细胞中铁含量;利用ELISA法测定各组细胞中ROS和MDA的水平;通过qRT-PCR技术检测各组细胞中SRXN1、GPX4、SLC7A11、ACSL4和LPCAT3基因的mRNA表达水平;通过Western-blot技术测定各组细胞中SRXN1的蛋白表达水平。结果 与NC+DMSO 组相比,NC+erastin组细胞中铁含量、ROS和MDA水平、ACSL4和LPCAT3基因的mRNA表达水平以及SRXN1的基因mRNA和蛋白表达水平均显著上升[(8.46±0.60)vs(13.64±0.37)、(132.04±15.21)vs(203.82±13.17)、(97.35±9.58)vs(209.32±8.78)、(1.00±0.06)vs(2.15±0.03)、(1.00±0.02)vs(1.58±0.02)、(1.00±0.05)vs(2.94±0.16)、(0.88±0.02)vs(1.18±0.03)](P<0.01),而细胞中GPX4和SLC7A11的基因mRNA表达水平均显著下降[(1.00±0.03)vs(0.33±0.02)、(1.00±0.08)vs(0.33±0.01)](P<0.0001)。与NC + erastin组相比,si-SRXN1 + erastin组细胞中铁含量、ROS和MDA水平和ACSL4和LPCAT3基因的mRNA表达水平均显著上升[(13.64±0.37)vs(20.91±0.96)、(203.82±13.17)vs(261.38±16.92)、(209.32±8.78)vs(293.86±7.65)、(2.15±0.03)vs(2.70±0.09)、(1.58±0.02)vs(1.86±0.08)](P<0.01),而细胞中GPX4和SLC7A11的基因mRNA表达水平以及SRXN1的基因mRNA和蛋白表达水平均显著下降[(0.33±0.02)vs(0.10±0.01)、(0.33±0.01)vs(0.14±0.001)、(2.94±0.16)vs(0.48±0.02)、(1.18±0.03)vs(0.64±0.06)](P<0.01)。结论 敲低SRXN1会升高细胞铁含量,促进氧化应激反应,加重肝癌细胞铁死亡;其机制可能与抑制GPX4和SLC7A11基因表达以减弱抗氧化能力和激活ACSL4和LPCAT3基因表达,从而促进脂质过氧化的形成有关。

关键词: Sulfiredoxin-1, 肝癌细胞, 铁死亡

Abstract: Objective To investigate the effect and mechanism of Sulfiredoxin-1 (SRXN1) on ferroptosis in hepatocellular carcinoma cells. Methods Cultured HepG2 cells were divided into the following three groups: negative control group (NC group, treated with dimethyl sulfoxide), eristin group (treated with 10 μM eristin, a ferroptosis inducer ), and si-SRXN1 group (si-SRXN1 group, treated with small interfering RNA of SRXN1 and erasin). The iron content of each group was assayed by the iron content assay kit; The reactive oxygen species (ROS) and MDA levels of each group was detected with enzyme-linked immunosorbent assay (ELISA); The mRNA expression level of SRXN1, GPX4, SLC7A11, ACSL4, and LPCAT3 genes was determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR); The expression level of SRXN1 protein was evaluated by Western-blot. Results Compared with the NC group, the cellular iron content [(8.46±0.60) vs (13.64±0.37)], ROS and MDA levels [(132.04±15.21) vs (203.82±13.17), and (97.35±9.58) vs (209.32±8.78)], the mRNA expression levels of ACSL4 and LPCAT3 [(1.00±0.06) vs (2.15±0.03), (1.00±0.02) vs (1.58±0.02)], as well as the expression levels of SRXN1 mRNA [(1.00±0.05) vs (2.94±0.16)] and protein [(0.88±0.02) vs (1.18±0.03)] were all significantly enhanced in the eristin group (P<0.01), whereas the expression of GPX4 and SLC7A11 were both prominently diminished in the eristin group [(1.00±0.03) vs (0.33±0.02), (1.00±0.08) vs (0.33±0.01)] (all P<0.0001). When compared with the eristin group, the cellular iron content [(13.64±0.37) vs (20.91±0.96)], ROS and MDA levels [(203.82±13.17) vs (261.38±16.92), (209.32±8.78) vs (293.86±7.65)], mRNA expression levels of ACSL4 [(2.15±0.03) vs (2.70±0.09)] and LPCAT3 [(1.58±0.02) vs (1.86±0.08)] were all substantially ascended (all P<0.01), but the mRNA expression levels of GPX4 [(0.33±0.02) vs (0.10±0.01)] and SLC7A11 [(0.33±0.01) vs (0.14±0.001)], as well as the expression levels of SRXN1 mRNA [(2.94±0.16) vs (0.48±0.02)] and protein [(1.18±0.03) vs (0.64±0.06)] were all dramatically declined in the si-SRXN1 group,(P<0.01). Conclusion Knocking-down SRXN1 elevates cellular iron content, promotes oxidative stress response, and aggravates ferroptosis in hepatocellular carcinoma cells induced by eristin, which may be related to an inhibition of GPX4 and SLC7A11 genes expression, therefore attenuate antioxidant capacity and activating the expression of ACSL4 and LPCAT3 genes to promote the formation of lipid peroxidation.

Key words: Sulfiredoxin-1, Hepatocellular carcinoma cells, Ferroptosis